





















（受理　平成 30 年 10 月 19 日）
Final Lecture 
Some Topics for the Placental Pathology
Mariko FUJIBAYASHI
Department of Pathology, Tokyo Women’s Medical University Medical Center East
Recent studies have elucidated the pathophysiology of the common placental disorders. It is believed that 
gestational hypertension, also known as preeclampsia, is a two-stage disease. Inadequate migration of the tro-
phoblasts induces defective remodeling of the uterine spiral arteries. The poorly perfused and re-perfused pla-
centa (Stage 1) produces antiangiogenic factors that cause maternal endothelial dysfunction (Stage 2). It has 
been hypothesized that a luck of fetomaternal immune tolerance leads to insufficient trophoblastic 
differentiation.
Another placental disorder is chronic villitis or villitis of unknown etiology. The diagnosis of severe chronic 
villitis is important to the clinician because it causes intrauterine growth restriction, fetal death, and neonatal 
neurological impairment. These lesions could be of immune origin. It has been reported that the pathogenesis 
of chronic placentitis is the maternal anti-fetal cellular and antibody-mediated rejection. 
Disorders of gestational immune tolerance underlie these two placental diorders.
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酸 素 感 受 性 転 換 因 子（hypoxia-inducible factor 1 
alfa：HIF-1α），非古典的主要組織適合性抗原（major 
histocompatibility complex：MHC）クラス I 分子
（クラス Ib）の human leukocyte antigen（HLA-G），


















娠 18～20 週に完成する（Fig. 2b）．
　妊娠高血圧では絨毛外栄養膜細胞の螺旋動脈への
Table　1　Classification of placental diseases
Developmental disorders
Multiple pregnancy, Molar pregnancy, Abnormal implan-
tation (Heterotooic pregnancy, Placental adhesion) etc.
Circulatory disorders






Metabolic diseases (Maternal diabetes, Fetal metabolic stor-
age diseases)
Placental neoplasms and metastatic neoplasms








Invasive interstitial trophoblast cells









a: The trophoblastic shell, plugs (arrow) the ends of 
the uteroplacental vessels (yellow broken line). 8th 
week of gestation. H & E. 200×(original magnification).
b: Enovascular invasion of the extravillous trophoblast 
involves the replacement of vascular smooth muscle 
and endothelial cells, and transforms the muscular 
type arteries into dilated arteries. 17th week of gesta-
tion. H & E. 100×(original magnification).
a
b
Fig.　3　Immunological aspect of abnormal remodeling 
of spiral arteries
Fig.　4　In preeclampsia, the vessels remain narrow 
and of the muscular type at the maternal-fetal inter-
face (the basal plate). 36th week of gestation. H & E. 
40×(inside. 100×) (original magnification).
Fig.　5　Schematic diagram of the spiral artery trans-
formation in normal pregnancy and in pregnancy 
with preeclampsia. Adapted from reference 3.
Fig.　6　Levels of circulating biomarkers induced by 




























ス I 分子も MHC クラス II 分子も発現しない．一方
で絨毛外栄養膜細胞には MHC クラス Ia の HLA-C，
MHC クラス Ib の HLA-G，HLA-E が発現し，HLA-C
は NK 細胞の抑制性受容体に結合して NK 細胞の細
胞傷害活性を抑制する．HLA-G も同様に，細胞傷害
性 T リンパ球（CD8 陽性）や NK 細胞の活性を抑制
する．脱落膜内の制御性 T リンパ球（regulatory T 
cell：Treg），組織球，樹状細胞も免疫寛容の役割を
担い，HLA-G が脱落膜の樹状細胞，組織球，NK 細




a. Atherosis of the spiral arteries from the preeclamp-
tic placenta. Fibrinoid necrosis of the vessel wall with 
subendothelial or foamy mural macrophages. H & E. 
40×(Left). 200×(Right).
b. A low-magnification view shows the elongated, thin 
villi with a few capillaries in each villous cross section, 
and the unusually wide intervillous space in the early 





a. In a case of late onset preeclampsia, the terminal 
villi show increased branching. This results in the 
appearance of numerous small sections, with highly 
capillarized terminal villi (Right). Distal villi also show 
agglomeration of the syncytial nuclei (Left). H & E. 40
×(original magnification).
b. The number of terminal villi and syncytial knots 
are increased at the 40th week of gestation (Left, 
H & E. 40×of original magnification). Terminal villi 





















a. In chronic villitis, immunostaining shows more CD8 
positive lymphocytes than CD4 positive lymphocytes. 
200×(original magnification).
b. CD68 immunostaining, a marker for histiocytes, re-
veals the histiocytes infiltrating the chorionic villi and 




a. In chronic villitis, several terminal villi are infiltrat-
ed by the lymphocytes with perivillous deposition of 
fibrinoid material. The intervillous space contains his-
tiocytes (arrow) ．H & E. 200×(original magnification).
b. Sometimes proximal villi are affected and associated 




Table　2　Overview of chronic villitis
・ Gershon, Strauss (1961). Structural changes in Placental insufficiency syndrome. Chronic villous inflammation, 
fibrin deposition and local obliteration of the circulation
・ Altshuler, Russell (1975). Villitis of unknown etiology: lack of evidence for an underlying microbial etiology
・ Redline, Patterson (1993). Villitis of unknown etiology is a T cell-mediated immune response










（vascular endothelial growth factor：VEGF）受容





婦では可溶性 VEGF 受容体 1（sFlt-1）が増加して
おり，フリーの PlGF，VEGF は減少していること
が観察される（Fig. 6）4）．





























遊走や血管新生を制御する VEGF 受容体 2 の細胞内
Fig.　11　A chart of chronic villitis illustrates maternal anti-fetal rejection through the pla-
centa. Maternal CD8＋T cells (red) infiltrate into the villi and release cytotoxic granules 
(granzyme and perforin). Subsequently, the villous histiocytes are activated, and release 
chemokines within the chorionic villi, and then increase chemokines in fetal and mater-
nal plasma. These events result from the cellular and/or humoral immune responses. 


































炎は 1960 年代に米国の Gershon と Strauss11）によっ
て，胎児の発育を妨げる胎盤病変の組織像として記
載された．感染症とは無関係な絨毛炎として感染症






















変の広がりの程度によって high grade と low grade
に分けられ15），low gradeでは妊娠満期まで無症状の
ことが少なくない．
　絨毛に浸潤する細胞は T リンパ球が 45% で，CD8
陽性の細胞傷害性 T リンパ球が優勢である（Fig. 
10a）．浸潤するリンパ球の約 9 割が母体由来である








a. A microscopic image of chronic villitis stained with 
H & E (Left 100×). C4d immunoreactivity is linear 
along the syncytiotrophoblast surface (Right 100×).
b. No C4d immunoreactivity in an almost normal pla-
centa at the 34th gestational week (Left. H & E). (Right. 












ラス I も MHC クラス II も発現しないが，慢性絨毛





胞傷害性 T リンパ球（CD8 陽性）は granzyme，
perforin などの細胞傷害性顆粒を放出し，また細胞



















で検出されるかどうか，過去 5 年間（2013～2017 年）
の 32 例の胎盤に C4d の免疫染色を行った．妊娠週
数は 33～41 週（平均 38 週）．使用した抗体は rabbit 
polyclonal antiC4d（Lot No. 41203. American 









Fig.　13　Two schematic diagrams represent the probable pathophysiology of the two pla-
cental disorders for a comparison.
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